Video-on-Demand Library


Collection
Keyword or phrase

Topic

28 April 2020

Jackie Moynihan

Read more...

Jackie Moynihan.

Given the current situation, pretty much everyone is working remotely from home. Some people are used to working remotely either on a regular or full-time basis this, whilst for many this is a new experience.

Remote working, whether chosen or forced, has pros and cons for the company, manager and the statistician. Based on over 15 years’ experience working from home as a contractor and more recently as a manager of home-based statisticians and programmers, this Webinar will give some guidance for both managers and individuals. Some technical advice will be covered but the focus will be on how to recruit and manage remote statisticians as well as some strategies for the day-to-day challenges of being home-based.

This webinar is aimed both at people who are used to working from home as well as at those are being asked to work from home for the first time. Not everyone will have an ideal home-working scenario and may also be juggling family needs at the same time. Areas where we need to adapt from the ideal will be discussed.

23 April 2020

Andy Grieve, Haolun Shi and Daniele De Martini

Read more...

Andy Grieve, Haolun Shi and Daniele De Martini.

Watch this Journal Club webinar on “Progressing II Data into Phase III”. Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9. 
Access the slides here.
 

 

23 April 2020

Lucy Rowell, Chrissie Fletcher & Nigel Howitt

Read more...

Lucy Rowell, Chrissie Fletcher & Nigel Howitt - Chrissie and Nigel share their thoughts on how PSI has helped them to be successful in their Careers, and what PSI has to offer to yourself as an individual or as a line manager.

08 April 2020

Alexander Schacht, Mark Baillie, Daniel Saure, Bodo Kirsch, Zachary Skrivanek, Lorenz Uhlmann, Rachel Phillips, Markus Vogler, David Carr and Steve Mallett.

Read more...

Alexander Schacht, Mark Baillie, Daniel Saure, Bodo Kirsch, Zachary Skrivanek, Lorenz Uhlmann, Rachel Phillips, Markus Vogler, David Carr and Steve Mallett.

The VIS SIG's new initiative, “Wonderful Wednesdays” is now underway. The aim of this initiative is to teach participants about visualisation principles and get them to apply what they learn to relevant examples from the field of healthcare and the development of new therapies. In this webinar we discuss the first submissions looking at some great ways to visualise a categorical response variable over time. We talk about what the SIG members like about each plot and give some pointers on areas we think could be improved.
More specifically, we talk about:
- the value of a title with conclusions
- the use of colour
- the benefits of animation to display time
- ways to declutter your graph and examples of clean design
- enclosure to highlight important parts of the data
- the benefits of the sankey diagram 
- how different charts help to answer different questions
- and many more aspects of great visualizations

We also introduce the second dataset about time to event analyses in a multi-arm study and invite submissions for our next challenge.

Data Submission
The data can be accessed and downloaded via this link: 
https://github.com/VIS-SIG/Wonderful-Wednesdays
Please then submit your material via our Google Form.
 

11 March 2020

Alexander Schacht, Mark Baillie, Daniel Saure, Bodo Kirsch, Zachary Skrivanek, Lorenz Uhlmann and Rachel Phillips.

Read more...

Alexander Schacht, Mark Baillie, Daniel Saure, Bodo Kirsch, Zachary Skrivanek, Lorenz Uhlmann and Rachel Phillips.

The VIS SIG is happy to introduce a new initiative called “Wonderful Wednesdays”. This initiative will provide the participants to not only learn theoretically about visualisation principles but also apply them to relevant examples from the field of healthcare and the development of new therapies. This webinar kicks off the webinar series by giving an introduction into principles of visualization and an overview of the process. The first dataset is also introduced.

Data Submission
The data can be accessed and downloaded via this link:
https://github.com/VIS-SIG/Wonderful-Wednesdays/tree/master/data/2020/2020-03-11
Please then submit your material via our Google Form

14 January 2020

Richard Pugh

Read more...

The last 15 years has seen a massive shift in the role of data and analytics, driven by the increased hype around big data, data science, machine learning and AI. This presents both challenges and opportunities for analytic teams. This webinar will strip back the hype to look at what these buzzwords really mean, and talk about the impact this is having on the role, remit and operating model of analytic teams in the life sciences industry.

10 December 2019

Pierre Colin, Juan Abellan, Gaëlle Saint-Hilary

Read more...

Pierre Colin, Juan Abellan, Gaëlle Saint-Hilary

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

03 December 2019

Véronique Robert, Guido Thömmes, Oliver Sailer

Read more...

Véronique Robert, Guido Thömmes, Oliver Sailer

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

20 November 2019

Chrissie Fletcher

Read more...

Chrissie Fletcher

This session covers an overview of ICH E17 (General Principles for Planning and Design of Multi-Regional Clinical Trials). This Guideline provides guidance on general principles on planning/designing Multi-Regional Clinical Trial (MRCT). Drug development has been globalised and MRCT for regulatory submission has widely been conducted in ICH regions and beyond. Regulatory agencies are currently facing some challenges in evaluating data from MRCTs for drug approval and it was deemed necessary to developed a Harmonised international Guideline to promote conducting MRCT appropriately, especially focusing on scientific issues in planning/designing MRCTs. This Guideline complements the guidance on MRCTs provided in ICH E5(R1) Guideline and facilitates MRCT data acceptance by multiple regulatory agencies.

20 November 2019

James Matcham

Read more...

James Matcham

This session covers an overview of Other Key Regional Statistical Documents. The topics covered include development planning, meta-analysis, non-inferiority studies, baseline covariates, Data Monitoring Committees, multiplicity, adaptive designs, endpoints and payer/reimbursment.

20 November 2019

James Matcham, Chrissie Fletcher, Kerry Gordon

Read more...

James Matcham, Chrissie Fletcher, Kerry Gordon

Question and Answer Session from the ICH for Statisticians training course. 

19 November 2019

Caroline Pothet

Read more...

Caroline Pothet

The first part of this session covers an overview of ICH guidelines and the founding members (FDA, EMA, PMDA). The second part of this session covers an overview of seeking scientific advice from regulators.
Page:

Upcoming Events

Latest Jobs